全文获取类型
收费全文 | 64333篇 |
免费 | 4512篇 |
国内免费 | 212篇 |
专业分类
耳鼻咽喉 | 800篇 |
儿科学 | 1424篇 |
妇产科学 | 848篇 |
基础医学 | 8196篇 |
口腔科学 | 966篇 |
临床医学 | 6839篇 |
内科学 | 13901篇 |
皮肤病学 | 789篇 |
神经病学 | 6432篇 |
特种医学 | 2188篇 |
外国民族医学 | 5篇 |
外科学 | 11521篇 |
综合类 | 627篇 |
一般理论 | 47篇 |
预防医学 | 4399篇 |
眼科学 | 1232篇 |
药学 | 4416篇 |
中国医学 | 71篇 |
肿瘤学 | 4356篇 |
出版年
2024年 | 64篇 |
2023年 | 500篇 |
2022年 | 871篇 |
2021年 | 2010篇 |
2020年 | 1213篇 |
2019年 | 1800篇 |
2018年 | 2190篇 |
2017年 | 1534篇 |
2016年 | 1633篇 |
2015年 | 1879篇 |
2014年 | 2706篇 |
2013年 | 3368篇 |
2012年 | 5260篇 |
2011年 | 5460篇 |
2010年 | 2932篇 |
2009年 | 2694篇 |
2008年 | 4395篇 |
2007年 | 4484篇 |
2006年 | 4279篇 |
2005年 | 4080篇 |
2004年 | 3640篇 |
2003年 | 3477篇 |
2002年 | 3095篇 |
2001年 | 433篇 |
2000年 | 330篇 |
1999年 | 393篇 |
1998年 | 622篇 |
1997年 | 483篇 |
1996年 | 381篇 |
1995年 | 327篇 |
1994年 | 289篇 |
1993年 | 271篇 |
1992年 | 208篇 |
1991年 | 163篇 |
1990年 | 130篇 |
1989年 | 112篇 |
1988年 | 118篇 |
1987年 | 101篇 |
1986年 | 92篇 |
1985年 | 82篇 |
1984年 | 118篇 |
1983年 | 98篇 |
1982年 | 110篇 |
1981年 | 102篇 |
1980年 | 113篇 |
1979年 | 51篇 |
1978年 | 49篇 |
1977年 | 47篇 |
1976年 | 38篇 |
1974年 | 34篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
21.
Christopher Gillberg 《Journal of autism and developmental disorders》1991,21(1):61-77
Autism is associated with epilepsy. One third of the population of people with autism have developed seizures in early adult life. In spite of this well-known association, little is known about the treatment of epilepsy in autism. This paper reviews the sparse literature and reports a systematic case-record study of the treatment of epilepsy in autism. Some practical guidelines for clinicians are provided. Research in the field of epilepsy in autism is highly warranted.This study has been supported by a grant from The Commission for Social Research, Sweden, No. E 88/170:2. 相似文献
22.
23.
24.
25.
Guerard W. Byrne Johannes M. Schirmer David N. Fass Sumeet S. Teotia Walter K. Kremers Hui Xu Bashoo Naziruddin Henry D. Tazelaar John S. Logan Christopher G. A. McGregor 《American journal of transplantation》2005,5(5):1011-1020
Microvascular thrombosis is a prominent feature in cardiac delayed xenograft rejection (DXR). We investigated the impact of warfarin or low-molecular-weight heparin (LMWH) anti-coagulation on xenograft function using a heterotopic pig-to-primate model. Donor hearts were from CD46 transgenic pigs and baboon immunosuppression included tacrolimus, sirolimus, anti-CD20 and TPC, an alpha-galactosyl-polyethylene glycol conjugate. Three groups of animals were studied. Group 1 (n = 9) was treated with warfarin, Group 2 (n = 13) with LMWH and Group 3, received no anti-coagulant drugs. The median duration of xenograft function was 20 days (range 3-62 days), 18 days (range 5-109 days) and 15 days (range 4-53 days) in Groups 1 to 3 respectively. Anti-coagulation achieved the targeted international normalized prothrombin ratio (INR) and anti-factor Xa levels consistent with effective in vivo therapy yet, no significant impact on median xenograft function was observed. At rejection, a similar histology of thrombosis and ischemia was apparent in each group and the levels of fibrin deposition and platelet thrombi in rejected tissue was the same. Anti-coagulation with warfarin or LMWH did not have a significant impact on the onset of DXR and microvascular thrombosis. However, a role for specific anti-coagulant strategies to achieve long-term xenograft function cannot be excluded. 相似文献
26.
Background contextLarge, prominent osteophytes along the anterior aspect of the cervical spine have been reported as a cause of dysphagia. Improvement of swallowing after surgical resection has been reported in a few case reports with short-term follow-up. The current report describes outcomes of a series of five patients with surgical treatment for this rare disorder, with a long-term follow-up.PurposeTo study the clinical and radiographic outcomes of a case series of patients surgically treated for dysphagia secondary to cervical diffuse idiopathic skeletal hyperostosis (DISH).Study designRetrospective review of a case series.Patient sampleFive cases from a University Hospital.Outcome measuresClinical and imagenological follow-up.MethodsThe records of five patients with dysphagia who had undergone anterior surgical resection of prominent osteophytes secondary to DISH were reviewed. Extrinsic esophageal compression secondary to anterior cervical osteophytes was radiographically confirmed via preoperative barium esophagogram swallowing study. All patients underwent anterior cervical osteophytes resection without fusion. Postoperatively, patients were followed-up clinically and radiographically with routine lateral cervical radiographs.ResultsPreoperative esophagogram showed that the esophageal obstruction was present at one level in three cases and two levels in two cases. The C3–C4 level was involved in three cases, C4–C5 in three cases, and C5–C6 in one case. There were no postoperative complications, including recurrent laryngeal nerve palsy, wound infection, or hematomas. All patients had resolution of dyphagia soon after surgery (within 2 weeks). Postoperative radiographs demonstrated complete removal of osteophytes. At final follow-up, ranging from 1 to 9 years (average 59.8 months, median 53 months), no patients reported recurrence of dysphagia. Final radiographic examination demonstrated minimal regrowth of the osteophytes.ConclusionsAlthough rarely indicated, surgical resection of anterior cervical osteophytes from DISH causing dyphagia produces good clinical and radiographical outcomes. After thorough evaluation to rule out other intrinsic or extrinsic causes of swallowing difficulty, surgical treatment of this uncommon condition might be considered. 相似文献
27.
28.
Betsy D. Kennard Susan G. Silva Simon Tonev Paul Rohde Jennifer L. Hughes Benedetto Vitiello Christopher J. Kratochvil John F. Curry Graham J. Emslie Mark Reinecke John March 《Journal of the American Academy of Child and Adolescent Psychiatry》2009,48(2):186-195
ObjectiveWe examine remission rate probabilities, recovery rates, and residual symptoms across 36 weeks in the Treatment for Adolescents with Depression Study (TADS).MethodThe TADS, a multisite clinical trial, randomized 439 adolescents with major depressive disorder to 12 weeks of treatment with fluoxetine, cognitive–behavioral therapy, their combination, or pill placebo. The pill placebo group, treated openly after week 12, was not included in the subsequent analyses. Treatment differences in remission rates and probabilities of remission over time are compared. Recovery rates in remitters at weeks 12 (acute phase remitters) and 18 (continuation phase remitters) are summarized. We also examined whether residual symptoms at the end of 12 weeks of acute treatment predicted later remission.ResultsAt week 36, the estimated remission rates for intention-to-treat cases were as follows: combination, 60%; fluoxetine, 55%; cognitive–behavioral therapy, 64%; and overall, 60%. Paired comparisons reveal that, at week 24, all active treatments converge on remission outcomes. The recovery rate at week 36 was 65% for acute phase remitters and 71% for continuation phase remitters, with no significant between-treatment differences in recovery rates. Residual symptoms at the end of acute treatment predicted failure to achieve remission at weeks 18 and 36.ConclusionsMost depressed adolescents in all three treatment modalities achieved remission at the end of 9 months of treatment. 相似文献
29.
30.